Last reviewed · How we verify

NCT06987279

Lactobacillus Plantarum and Hormonal Regulation in Obese Women

Recruiting now NA Last updated 23 May 2025
What this trial tests

NA trial testing Probiotic in Obesity, Women in 100 participants. Currently enrolling.

Timeline
10 June 2025
Primary endpoint
10 September 2025
10 December 2025

Quick facts

Lead sponsorWecare Probiotics Co., Ltd.
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment100
Start date10 June 2025
Primary completion10 September 2025
Estimated completion10 December 2025
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Wecare Probiotics Co., Ltd. — full company profile →

Who can join

Adults 18 to 40, female only, with Obesity, Women. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To evaluate the regulatory effect of Lactobacillus plantans Lp90 formula on visceral fat metabolism and sex hormone balance in obese women.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Probiotic

Trials testing the same drug.

Other recruiting trials for Obesity, Women

Currently open trials in the same condition.

Other Wecare Probiotics Co., Ltd. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06987279.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing